(KER) Kering - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000121485
Stock: Fashion, Leather, Jewelry, Eyewear, Beauty
Total Rating 49
Risk 82
Buy Signal -0.62
| Risk 5d forecast | |
|---|---|
| Volatility | 38.1% |
| Relative Tail Risk | -14.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | -2.13 |
| Character TTM | |
|---|---|
| Beta | 1.018 |
| Beta Downside | 1.569 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.00% |
| CAGR/Max DD | -0.25 |
Description: KER Kering February 28, 2026
Kering SA (ticker KER) is a French luxury conglomerate that designs, manufactures and markets a portfolio of high-end fashion, leather goods, jewelry and beauty brands-including Gucci, Saint Laurent, Bottega Veneta, Balenciaga and Alexander McQueen-across Asia-Pacific, Western Europe, North America, Japan and other global markets.
In FY 2023 the group generated €19.8 billion in revenue, up 13% year-on-year, with an operating margin of 17.6% driven by strong demand for leather goods in Asia-Pacific (+12% YoY) and robust digital sales growth (e-commerce now accounts for 23% of total sales). The luxury sector is projected to expand at a 5% CAGR through 2027, supported by rising affluent consumer spending and continued brand-level investments in sustainability and omnichannel experiences.
For a deeper dive into Kering’s valuation and outlook, you might explore additional analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.12 > 1.0 |
| NWC/Revenue: 8.49% < 20% (prev 11.00%; Δ -2.51% < -1%) |
| CFO/TA 0.16 > 3% & CFO 6.68b > Net Income 1.21b |
| Net Debt (19.28b) to EBITDA (11.19b): 1.72 < 3 |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.9m) vs 12m ago 0.39% < -2% |
| Gross Margin: 73.24% > 18% (prev 0.76%; Δ 7248 % > 0.5%) |
| Asset Turnover: 77.21% > 50% (prev 72.49%; Δ 4.72% > 0%) |
| Interest Coverage Ratio: 5.62 > 6 (EBITDA TTM 11.19b / Interest Expense TTM 1.25b) |
Altman Z'' 2.80
| A: 0.07 (Total Current Assets 10.76b - Total Current Liabilities 8.05b) / Total Assets 41.18b |
| B: 0.36 (Retained Earnings 14.90b / Total Assets 41.18b) |
| C: 0.17 (EBIT TTM 7.03b / Avg Total Assets 41.27b) |
| D: 0.05 (Book Value of Equity 1.16b / Total Liabilities 25.67b) |
| Altman-Z'' Score: 2.80 = A |
Beneish M -2.96
| DSRI: 1.07 (Receivables 1.31b/1.15b, Revenue 31.87b/29.99b) |
| GMI: 1.04 (GM 73.24% / 75.86%) |
| AQI: 1.12 (AQ_t 0.52 / AQ_t-1 0.46) |
| SGI: 1.06 (Revenue 31.87b / 29.99b) |
| TATA: -0.13 (NI 1.21b - CFO 6.68b) / TA 41.18b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of KER shares?
As of February 28, 2026, the stock is trading at EUR 285.90 with a total of 341,537 shares traded.
Over the past week, the price has changed by +2.84%, over one month by +4.15%, over three months by -1.97% and over the past year by +7.20%.
Over the past week, the price has changed by +2.84%, over one month by +4.15%, over three months by -1.97% and over the past year by +7.20%.
Is KER a buy, sell or hold?
Kering has no consensus analysts rating.
What are the forecasts/targets for the KER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 299.6 | 4.8% |
| Analysts Target Price | - | - |
KER Fundamental Data Overview February 22, 2026
Market Cap USD = 40.33b (34.09b EUR * 1.1832 EUR.USD)
P/E Forward = 30.581
P/S = 2.3229
P/B = 2.2971
P/EG = 2.6097
Revenue TTM = 31.87b EUR
EBIT TTM = 7.03b EUR
EBITDA TTM = 11.19b EUR
Long Term Debt = 10.31b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.23b EUR (from shortTermDebt, last quarter)
Debt = 23.60b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.28b EUR (from netDebt column, last quarter)
Enterprise Value = 53.37b EUR (34.09b + Debt 23.60b - CCE 4.31b)
Interest Coverage Ratio = 5.62 (Ebit TTM 7.03b / Interest Expense TTM 1.25b)
EV/FCF = 17.39x (Enterprise Value 53.37b / FCF TTM 3.07b)
FCF Yield = 5.75% (FCF TTM 3.07b / Enterprise Value 53.37b)
FCF Margin = 9.63% (FCF TTM 3.07b / Revenue TTM 31.87b)
Net Margin = 3.78% (Net Income TTM 1.21b / Revenue TTM 31.87b)
Gross Margin = 73.24% ((Revenue TTM 31.87b - Cost of Revenue TTM 8.53b) / Revenue TTM)
Gross Margin QoQ = 72.25% (prev 73.01%)
Tobins Q-Ratio = 1.30 (Enterprise Value 53.37b / Total Assets 41.18b)
Interest Expense / Debt = 1.33% (Interest Expense 314.0m / Debt 23.60b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 5.27b (EBIT 7.03b * (1 - 25.00%))
Current Ratio = 1.34 (Total Current Assets 10.76b / Total Current Liabilities 8.05b)
Debt / Equity = 1.60 (Debt 23.60b / totalStockholderEquity, last quarter 14.71b)
Debt / EBITDA = 1.72 (Net Debt 19.28b / EBITDA 11.19b)
Debt / FCF = 6.28 (Net Debt 19.28b / FCF TTM 3.07b)
Total Stockholder Equity = 14.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 1.21b / Total Assets 41.18b)
RoE = 8.13% (Net Income TTM 1.21b / Total Stockholder Equity 14.82b)
RoCE = 27.99% (EBIT 7.03b / Capital Employed (Equity 14.82b + L.T.Debt 10.31b))
RoIC = 18.82% (NOPAT 5.27b / Invested Capital 28.03b)
WACC = 6.12% (E(34.09b)/V(57.68b) * Re(9.67%) + D(23.60b)/V(57.68b) * Rd(1.33%) * (1-Tc(0.25)))
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.19%
[DCF] Terminal Value 82.60% ; FCFF base≈3.09b ; Y1≈2.46b ; Y5≈1.64b
[DCF] Fair Price = 226.8 (EV 47.09b - Net Debt 19.28b = Equity 27.81b / Shares 122.6m; r=6.12% [WACC]; 5y FCF grow -24.62% → 2.90% )
EPS Correlation: -27.43 | EPS CAGR: -69.17% | SUE: 0.0 | # QB: 0
Revenue Correlation: -16.31 | Revenue CAGR: -3.37% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=7.26 | Chg7d=-0.447 | Chg30d=-1.065 | Revisions Net=-7 | Growth EPS=+67.8% | Growth Revenue=+1.9%
EPS next Year (2027-12-31): EPS=10.84 | Chg7d=-0.355 | Chg30d=-0.748 | Revisions Net=-5 | Growth EPS=+49.2% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 7 Down within 30d for Current Year)
P/E Forward = 30.581
P/S = 2.3229
P/B = 2.2971
P/EG = 2.6097
Revenue TTM = 31.87b EUR
EBIT TTM = 7.03b EUR
EBITDA TTM = 11.19b EUR
Long Term Debt = 10.31b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.23b EUR (from shortTermDebt, last quarter)
Debt = 23.60b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.28b EUR (from netDebt column, last quarter)
Enterprise Value = 53.37b EUR (34.09b + Debt 23.60b - CCE 4.31b)
Interest Coverage Ratio = 5.62 (Ebit TTM 7.03b / Interest Expense TTM 1.25b)
EV/FCF = 17.39x (Enterprise Value 53.37b / FCF TTM 3.07b)
FCF Yield = 5.75% (FCF TTM 3.07b / Enterprise Value 53.37b)
FCF Margin = 9.63% (FCF TTM 3.07b / Revenue TTM 31.87b)
Net Margin = 3.78% (Net Income TTM 1.21b / Revenue TTM 31.87b)
Gross Margin = 73.24% ((Revenue TTM 31.87b - Cost of Revenue TTM 8.53b) / Revenue TTM)
Gross Margin QoQ = 72.25% (prev 73.01%)
Tobins Q-Ratio = 1.30 (Enterprise Value 53.37b / Total Assets 41.18b)
Interest Expense / Debt = 1.33% (Interest Expense 314.0m / Debt 23.60b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 5.27b (EBIT 7.03b * (1 - 25.00%))
Current Ratio = 1.34 (Total Current Assets 10.76b / Total Current Liabilities 8.05b)
Debt / Equity = 1.60 (Debt 23.60b / totalStockholderEquity, last quarter 14.71b)
Debt / EBITDA = 1.72 (Net Debt 19.28b / EBITDA 11.19b)
Debt / FCF = 6.28 (Net Debt 19.28b / FCF TTM 3.07b)
Total Stockholder Equity = 14.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 1.21b / Total Assets 41.18b)
RoE = 8.13% (Net Income TTM 1.21b / Total Stockholder Equity 14.82b)
RoCE = 27.99% (EBIT 7.03b / Capital Employed (Equity 14.82b + L.T.Debt 10.31b))
RoIC = 18.82% (NOPAT 5.27b / Invested Capital 28.03b)
WACC = 6.12% (E(34.09b)/V(57.68b) * Re(9.67%) + D(23.60b)/V(57.68b) * Rd(1.33%) * (1-Tc(0.25)))
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.19%
[DCF] Terminal Value 82.60% ; FCFF base≈3.09b ; Y1≈2.46b ; Y5≈1.64b
[DCF] Fair Price = 226.8 (EV 47.09b - Net Debt 19.28b = Equity 27.81b / Shares 122.6m; r=6.12% [WACC]; 5y FCF grow -24.62% → 2.90% )
EPS Correlation: -27.43 | EPS CAGR: -69.17% | SUE: 0.0 | # QB: 0
Revenue Correlation: -16.31 | Revenue CAGR: -3.37% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=7.26 | Chg7d=-0.447 | Chg30d=-1.065 | Revisions Net=-7 | Growth EPS=+67.8% | Growth Revenue=+1.9%
EPS next Year (2027-12-31): EPS=10.84 | Chg7d=-0.355 | Chg30d=-0.748 | Revisions Net=-5 | Growth EPS=+49.2% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 7 Down within 30d for Current Year)